OraSure Technologies to Present at Upcoming Investor Conferences

Rhea-AI Summary

OraSure Technologies, Inc. (NASDAQ: OSUR) announced that Dr. Stephen S. Tang, President and CEO, will speak at two upcoming investor conferences. The first event is the Citi Spotlight on Diagnostics in a COVID-19 Environment on September 1, 2020, where Dr. Tang will participate in a panel at 12:05 PM EDT. The second is Baird’s 2020 Global Healthcare Conference on September 10, 2020, at 12:50 PM EDT. Investors can access the presentations via OraSure's website, with a replay available for 14 days.

BETHLEHEM, Pa., Aug. 27, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the following upcoming investor conferences:

• Citi Spotlight on Diagnostics in a COVID-19 Environment: Dr. Tang is scheduled to participate in a panel discussion titled “Disruptors in Diagnostic Testing” on September 1, 2020 at 12:05 PM Eastern Daylight Time (9:05 AM Pacific Time).
  
  
• Baird’s 2020 Global Healthcare Conference: Dr. Tang is scheduled to speak on September 10, 2020 at 12:50 PM Eastern Daylight Time (9:50 AM Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies’ web site for 14 days. Alternatively, you can access the live webcast of the presentation via the following link: https://kvgo.com/rwbaird/orasure-september-2020.

About OraSure Technologies

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, CoreBiome (now operating under the Diversigen brand), UrSure, and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.

Company contacts:

Sam Martin
Argot Partners
212-600-1902
OraSure@argotpartners.com

Jeanne Mell
VP Corporate Communications
484-353-1575
media@orasure.com
www.orasure.com

FAQ

When is Dr. Stephen S. Tang speaking at the Citi Spotlight on Diagnostics conference?

Dr. Tang will speak at the Citi Spotlight on Diagnostics conference on September 1, 2020, at 12:05 PM EDT.

What is the date and time for Dr. Tang's presentation at Baird’s 2020 Global Healthcare Conference?

Dr. Tang will present at Baird’s 2020 Global Healthcare Conference on September 10, 2020, at 12:50 PM EDT.

How can investors access the webcasts of Dr. Tang's presentations?

Investors can access the live webcasts of Dr. Tang's presentations on OraSure Technologies' website under the Investor Info section.

Is there a replay available for the webcasts of the presentations?

Yes, replays of the presentations will be available on OraSure Technologies' website for 14 days after the events.

What topics will Dr. Tang discuss at the conferences?

Dr. Tang will discuss topics related to disruptors in diagnostic testing at the Citi conference and other healthcare insights at Baird’s conference.